Human Bone Marrow Stromal Antigen 2 (BST2) Protein

Este producto es parte de BST2 - bone marrow stromal cell antigen 2
Product Graph
416€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Bone Marrow Stromal Antigen 2 (BST2) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx657446
tested applications
WB, SDS-PAGE

Description

Human Bone Marrow Stromal Antigen 2 (BST2) protein is a recombinant Human protein expressed in 293F cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Bone Marrow Stromal Antigen 2 (BST2)
Host
293F cells
Assay Type
Activity: Not tested
Sequence Fragment: Asn49-Ser161
Tag: N-terminal His tag
Origin
Human
Conjugation
Unconjugated
Observed MW
Calculated MW: 14.2 kDa  Observed MW (SDS-PAGE): 24 kDa
Expression
Recombinant
Purity
> 90%
Size 1
50 µg
Size 2
100 µg
Size 3
200 µg
Size 4
500 µg
Size 5
1 mg
Form
Lyophilized
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
Availability
Shipped within 5-7 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
UniProt ID
Q10589
Gene ID
684
Background
Protein BST2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Endotoxin Level: < 1.0 EU per 1 µg (determined by the LAL method)
Concentration: Prior to lyophilization: 200 µg/ml

Descripción

Related Products

EH6764

Human BST2 (Bone marrow stromal antigen 2) ELISA Kit

Ver Producto
FNab00970

BST2 antibody

IFN-induced antiviral host restriction factor which efficiently blocks the release of diverse mammalian enveloped viruses by directly tethering nascent virions to the membranes of infected cells. Acts as a direct physical tether, holding virions to the cell membrane and linking virions to each other. The tethered virions can be internalized by endocytosis and subsequently degraded or they can remain on the cell surface. In either case, their spread as cell-free virions is restricted. Its target viruses belong to diverse families, including retroviridae: human immunodeficiency virus type 1(HIV-1), human immunodeficiency virus type 2(HIV-2), simian immunodeficiency viruses(SIVs), equine infectious anemia virus(EIAV), feline immunodeficiency virus(FIV), prototype foamy virus(PFV), Mason-Pfizer monkey virus(MPMV), human T-cell leukemia virus type 1(HTLV-1), Rous sarcoma virus(RSV) and murine leukemia virus(MLV), flavivirideae: hepatitis C virus(HCV), filoviridae: ebola virus(EBOV) and marburg virus(MARV), arenaviridae: lassa virus(LASV) and machupo virus(MACV), herpesviridae: kaposis sarcoma-associated herpesvirus(KSHV), rhabdoviridae: vesicular stomatitis virus(VSV), orthomyxoviridae: influenza A virus, and paramyxoviridae: nipah virus. Can inhibit cell surface proteolytic activity of MMP14 causing decreased activation of MMP15 which results in inhibition of cell growth and migration. Can stimulate signaling by LILRA4/ILT7 and consequently provide negative feedback to the production of IFN by plasmacytoid dendritic cells in response to viral infection. Plays a role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. Isoform 1 and isoform 2 are both effective viral restriction factors but have differing antiviral and signaling activities. Isoform 2 is resistant to HIV-1 Vpu-mediated degradation and restricts HIV-1 viral budding in the presence of Vpu. Isoform 1 acts as an activator of NF-kappa-B and this activity is inhibited by isoform 2.

Ver Producto
Pr22815

Recombinant Human BST2

Ver Producto